Salvatore Calabrese

Insider Reports History

Location
Bethesda, MD
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Salvatore Calabrese:

Company Role Class Num Shares Value Price $ Report Date Ownership
Gain Therapeutics, Inc. Chief Financial Officer Restricted Stock Units 25,000 $62,500 $2.50 23 Mar 2023 Direct
Gain Therapeutics, Inc. Chief Financial Officer Employee Stock Option (right to buy) 50,000 23 Mar 2023 Direct

Insider Reports Filed by Salvatore Calabrese

Symbol Company Period Transactions Value $ Form Type Role Filing Time
GANX Gain Therapeutics, Inc. 23 Mar 2023 2 $0 4 Chief Financial Officer 27 Mar 2023, 17:28
GANX Gain Therapeutics, Inc. 15 Jul 2022 2 $0 4 Chief Financial Officer 19 Jul 2022, 16:37
GANX Gain Therapeutics, Inc. 19 May 2022 1 +$8,100 4/A CHIEF FINANCIAL OFFICER 23 May 2022, 16:00